RPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net interest income is the income earned by banks from the fund they have on their balance sheet. Repros Therapeutics, Inc.'s net interest income for the three months ended in Dec. 2013 was $-0.01 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2013 was $-0.00 Mil.
Repros Therapeutics, Inc.'s quarterly net interest income increased from Jun. 2013 ($0.00 Mil) to Sep. 2013 ($0.00 Mil) but then declined from Sep. 2013 ($0.00 Mil) to Dec. 2013 ($-0.01 Mil).
Income earned by banks from the fund they have on their balance sheet. These funds can be from customers' deposit, bank's own equity or borrowed.
Repros Therapeutics, Inc. Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2013 was 0.001 (Mar. 2013 ) + 0 (Jun. 2013 ) + 0.003 (Sep. 2013 ) + -0.006 (Dec. 2013 ) = $-0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Repros Therapeutics, Inc. Annual Data
Repros Therapeutics, Inc. Quarterly Data